US IP Index Based On 'Flawed' Assumptions, Claim Indian Pharma Firms
Executive Summary
Indian drug makers have blasted the US Chamber of Commerce’s Global Innovation Policy Center over its International IP Index, saying its compilation is based on a “flawed” assumption that stronger patents drive greater innovation, and that it ignores individual national concerns.